1-3 of 3
Amy B. Heimberger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model

Shihong Zhang, R. Graeme Black, Karan Kohli, Brian J. Hayes, Cassandra Miller, Amanda Koehne, Brett A. Schroeder, Kraig Abrams, Brian C. Schulte, Borislav A. Alexiev, Amy B. Heimberger, Ali Zhang, Weiqing Jing, Juliana Chi Kei Ng, Himaly Shinglot, Bernard Seguin, Alexander I. Salter, Stanley R. Riddell, Michael C. Jensen, Stephen Gottschalk, Peter F. Moore, Beverly Torok-Storb, Seth M. Pollack
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (6): 999–1009.
https://doi.org/10.1158/1535-7163.MCT-21-0726
Published: 01 June 2022
View article titled, B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
Open the PDF for B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model in another window
Includes: Supplementary data
Journal Articles

Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

Jun Wei, Jason Barr, Ling-Yuan Kong, Yongtao Wang, Adam Wu, Amit K. Sharma, Joy Gumin, Verlene Henry, Howard Colman, Waldemar Priebe, Raymond Sawaya, Frederick F. Lang, Amy B. Heimberger
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (1): 67–78.
https://doi.org/10.1158/1535-7163.MCT-09-0734
Published: 12 January 2010
View article titled, Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
Open the PDF for Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway in another window
Journal Articles

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

John H. Sampson, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, James E. Herndon, II, Denise Lally-Goss, Sharon McGehee-Norman, Alison Paolino, David A. Reardon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2773–2779.
https://doi.org/10.1158/1535-7163.MCT-09-0124
Published: 12 October 2009
View article titled, An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
Open the PDF for An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme in another window